Laureate Pharma, Inc. has secured $20 million to finance five investment initiatives over the course of three years. “This marks a significant milestone in our efforts to relaunch Laureate Pharma,” said Michael A. Griffith, chief executive officer. “Our strategically planned improvements coupled with our solid financial footing will position us for exceptional growth. As we transform Laureate, care will be taken to maintain continuity of client services. Quality Assurance will ...